このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Sichuan Kelun Pharmaceutical マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Sichuan Liu

最高経営責任者

CN¥4.8m

報酬総額

CEO給与比率	n/a
CEO在任期間	15.3yrs
CEOの所有権	0.5%
経営陣の平均在職期間	8.7yrs
取締役会の平均在任期間	3.3yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Sichuan Liu (40 yo)

15.3yrs

在職期間

CN¥4,800,000

報酬

Mr. Sichuan Liu has been a Director of Sichuan Kelun Pharmaceutical Co., Ltd. since June 26, 2009 and serves as its General Manager. He is a Non-Executive Director of Sichuan Kelun-Biotech Biopharmaceutica...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Sichuan Liu	GM & Director	no data	CN¥4.80m	0.52% CN¥ 247.5m
Degui Lai	CFO & Deputy GM	9.9yrs	CN¥3.00m	0.033% CN¥ 15.6m
Zhonghua Wu	Deputy General Manager	8.7yrs	CN¥2.89m	0.010% CN¥ 4.9m
Wendi Fan	Deputy General Manager	2.4yrs	CN¥3.10m	0.0094% CN¥ 4.4m
Junyou Ge	Deputy GM & Director	no data	CN¥134.60k	データなし
Hao Feng	Deputy GM & Secretary of the Board of Directors	13.4yrs	CN¥3.00m	0.032% CN¥ 15.2m
Deguang Chen	Officer	no data	CN¥700.00k	データなし
Tan Hongbo	Deputy General Manager	11.3yrs	CN¥3.00m	0.017% CN¥ 7.9m
Tao Ge	Deputy General Manager	9.6yrs	CN¥3.00m	0.011% CN¥ 5.3m
Nanchao Ding	Deputy General Manager	4.4yrs	CN¥2.40m	データなし
Yihong Liao	Deputy General Manager	2.4yrs	CN¥1.65m	0.0076% CN¥ 3.6m
Liang Wang	Deputy General Manager	2.4yrs	CN¥900.00k	0.0031% CN¥ 1.5m

8.7yrs

平均在職期間

48yo

平均年齢

経験豊富な経営陣: 002422の経営陣は経験豊富で経験豊富です（平均在職期間は8.9年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Sichuan Liu	GM & Director	15.3yrs	CN¥4.80m	0.52% CN¥ 247.5m
Junyou Ge	Deputy GM & Director	less than a year	CN¥134.60k	データなし
Gexin Liu	Chairman of the Board of Directors	no data	CN¥2.00m	23.83% CN¥ 11.2b
Guosheng He	Non Independent Director	5.4yrs	CN¥100.00k	データなし
Changyan Zheng	Employee-Representative Member of the Board of Supervisors	16.3yrs	データなし	0.0039% CN¥ 1.8m
Jinbo Gao	Independent Director	3.3yrs	CN¥100.00k	データなし
Guangji Wang	Non Independent Director	10.3yrs	CN¥100.00k	データなし
Fuqing Wang	Director	less than a year	データなし	データなし
Wan Peng	Chairman of Board of Supervisors	9.5yrs	データなし	0.00063% CN¥ 297.2k
Jinbo Gao		3.3yrs	データなし	データなし
Shichi Ren	Independent Director	3.3yrs	CN¥100.00k	データなし
Xianxiang Zhou	Director	less than a year	データなし	データなし

3.3yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: 002422の取締役会は経験豊富であると考えられます ( 6.8年の平均在任期間)。

Sichuan Kelun Pharmaceutical マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

High number of new directors

High number of new directors

High number of new directors

Sichuan Kelun Pharmaceutical Co., Ltd., Annual General Meeting, May 05, 2022

Recent updates

Sichuan Kelun Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for the First Half of 2024

Sichuan Kelun Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023

First quarter 2024 earnings released: EPS: CN¥0.67 (vs CN¥0.57 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥1.69 (vs CN¥1.22 in FY 2022)

Sichuan Kelun Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment improves as stock rises 15%

Sichuan Kelun Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.38 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.43 in 2Q 2022)

Sichuan Kelun Pharmaceutical Co., Ltd. Announces Cash Dividend on Share A for 2022, Payable on May 15, 2023

Sichuan Kelun Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022

Full year 2022 earnings released: EPS: CN¥1.22 (vs CN¥0.78 in FY 2021)

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

High number of new directors

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.23 in 2Q 2021)

Sichuan Kelun Pharmaceutical Co., Ltd. Announces Final Distribution for the Year 2021, Payable on 16 May 2022

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.12 in 1Q 2021)

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) announces an Equity Buyback for CNY 200 million worth of its shares.

High number of new directors

Sichuan Kelun Pharmaceutical Co., Ltd., Annual General Meeting, May 05, 2022

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Full year 2021 earnings released: EPS: CN¥0.78 (vs CN¥0.58 in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.21 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.10 in 2Q 2020)

Sichuan Kelun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 3 billion in funding

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.58 (vs CN¥0.66 in FY 2019)

Investor sentiment improved over the past week

New 90-day high: CN¥21.88

New 90-day low: CN¥18.06

New 90-day low: CN¥20.47

New 90-day low: CN¥21.62

Revenue misses expectations

Third quarter earnings released

Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) entered into an agreement to acquire Shanghai Century Acquisition Corporation (Amex: SHA) in a reverse merger transaction.

First half earnings released

New 90-day high - CN¥25.76

Sichuan Kelun Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020

New 90-day high - CN¥23.83

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34